Neostigmine Methylsulfate Injection
Product Images NDC 68083-384

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 68083-384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neostigmine-spl-carton-1-10 (Neostigmine Spl Carton 1 10)

Packaging label for Neostigmine Methylsulfate Injection, USP 1 mg/mL (10 mg/10 mL) solution for intravenous use. The label indicates 10 x 10 mL multiple dose vials, labeled by Gland Pharma Limited. The label includes usage instructions, storage guidelines, and a barcode for tracking.*

FDA Label Image

Neostigmine-spl-carton-1 (Neostigmine Spl Carton 1)

Packaging label for Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) by Gland Pharma Limited. The label identifies the product as an intravenous injection in a 10 mL multiple dose vial, for human prescription use only. It includes dosage strength, manufacturer details, NDC 68083-384-01, storage instructions, and preservative information.*

FDA Label Image

Neostigmine-spl-carton-5-1 (Neostigmine Spl Carton 5 1)

Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) intravenous injection in a 10 mL multiple dose vial. The label indicates it is for prescription use only and includes storage instructions and a list of inactive ingredients. Manufactured by Gland Pharma Limited, Hyderabad, India, the packaging shows the product NDC 68083-383-01 and includes a barcode.*

FDA Label Image

Neostigmine-spl-carton-5-10 (Neostigmine Spl Carton 5 10)

Packaging label for Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) for intravenous use. The label indicates multiple 10 mL vials per package with a total of 10 vials. It includes the NDC number 68083-383-10 and notes the labeler as Gland Pharma Limited. The label contains usage instructions and regulatory information.*

FDA Label Image

Neostigmine-spl-structure (Neostigmine Spl Structure)

Chemical structure of neostigmine methylsulfate showing its molecular arrangement, including the ester linkage, quaternary ammonium group, and sulfate ion.*

FDA Label Image

Neostigmine-spl-vial-1 (Neostigmine Spl Vial 1)

Neostigmine methylsulfate Injection USP 1 mg/mL (10 mg/10 mL) vial label for intravenous use. The label includes formulation details, storage instructions, and manufacturer information: Gland Pharma Limited, Hyderabad, India. It is a 10 mL multiple-dose vial labeled for prescription use only.*

FDA Label Image

Neostigmine-spl-vial-5 (Neostigmine Spl Vial 5)

Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) single-use vial label by Gland Pharma Limited. The label includes active ingredients per mL, storage instructions to protect from light and store between 20° to 25°C, and packaging details of a 10 mL multiple-dose vial for intravenous use. The label states prescription use only and the product is sterile for injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.